Home/Directory/Contract Research Organization/Translational Research in Oncology (TRIO)

Translational Research in Oncology (TRIO)

Edmonton, AB · Canada

Contract Research Organizationmid

Specialization: Full-service oncology CRO

Key Differentiator

Oncology-only CRO whose NATALEE (TRIO033) trial supported FDA approval of adjuvant ribociclib.

Core Services

Phase I to III oncology trials; Trial design with KOL input; Investigator network management; Patient access and engagement; Data analysis and results reporting

Capabilities

Phase III registration trialsFirst in human studiesNetwork of 500+ sites in 20+ countriesOver 22,000 patients enrolledUS site management via TRIO US SMO

Market Intelligence

Started in 1997 as BCIRG and renamed TRIO in 2011. Not-for-profit with University of Alberta roots, more than 200 staff, and hubs in Edmonton, Paris and Montevideo.

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.